Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ resapp health limited

RAP media thread., page-15

First 15 Last

Share
Profile

Follow
Xodiac

141 Posts.

9

17/09/19

18:36

Post #: 40456367
Share

Originally posted by AlCp: ↑

I can't see why eHealth and hospital/ER industries and humanitarian organisation wouldn't want a product like this as it's quick and accurate diagnosis saving them a bundle on resources and additional (X-ray/blood sample) cost and insurance cost.

I can see initial resistance from GP as they make a bucket load from respiratory disease diagnosis with their 30 minute consultation (excluding blood sample and X-ray) reduced to only 10-15 minutes but it does mean if they use ResAppDx, they will be able to see more patients in that time frame and more importantly less stress on them trying to diagnosis it correctly given it's so difficult using X-ray and blood sample let alone with just the stethoscope....and more importantly less insurance cost.

Expand

Agreed on the first, and I think doctors wouldn't take too long to adopt either. Standard consult times are typically 15 mins with 30 mins being considered a long consult, as far as I'm aware. So, I'd think they'd be quite happy to be using ResApp and also using the stethoscope, showing the patient they've got the tech but still giving the personal touch.

RAP Price at posting: 20.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 3,382 more messages in this thread...

First 15 Last

Add RAP (ASX) to my watchlist